N
PNT

Nuveen’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Nuveen’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-995,217
Closed -$6.64M – 3383
2023
Q3 		$6.64M Sell
995,217
-112,549
-10% -$935K ﹤0.01% 1723
2023
Q2 		$10M Buy
1,107,766
+670,732
+153% +$5.92M ﹤0.01% 1507
2023
Q1 		$3.18M Buy
437,034
+23,498
+6% +$174K ﹤0.01% 2136
2022
Q4 		$3.01M Buy
413,536
+150,424
+57% +$1.12M ﹤0.01% 2192
2022
Q3 		$2.03M Sell
263,112
-2,035
-0.8% -$17.3K ﹤0.01% 2397
2022
Q2 		$1.81M Buy
265,147
+223,330
+534% +$1.71M ﹤0.01% 2486
2022
Q1 		$271K Buy
+41,817
New +$266K ﹤0.01% 3140

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Nuveen's PNT Position: Q4 2023 in Review

Nuveen sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 995,217 shares — an estimated $6.64M sold.

Nuveen first reported a position in PNT in Q1 2022 and held it in 7 quarters. The position peaked at $10M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Nuveen reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 995,217 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $6.64M.
  • Nuveen first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Nuveen's POINT Biopharma Global Inc. Common Stock position peaked at $10M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.